SCO-267 is under development for the treatment of non-alcoholic steatohepatitis (NASH), diabetes, nonalcoholic fatty liver disease and obesity. It acts by targeting GPR40. It is administered through ...
Scohia Pharma (Scohia) is a drug discovery company that discovers and develops novel therapies for lifestyle-related diseases including cardiovascular, metabolic, and renal disease. It conducts ...
"I'm a nurse, so I'm around illness a lot, but it's different when it's your kids," Heninger said. In 2013, Heninger found out Jack had congenital nephrotic syndrome, a condition that affects kidney ...
Nephrotic syndrome (NS) represents a prevalent syndrome among various chronic kidney disease pathologies and is known for its higher severity and worse prognosis compared with chronic ...
Treatment was based on corticosteroids alone followed by immunosuppressants with no significant difference (p = 0.82). Partial remission was noted in 9 patients with LGM, i.e. 69.2%, and total ...
Some cases may be treated with radiation to reduce swelling in eye muscle and tissue. Symptoms of nephrotic syndrome can occur in people with an underlying kidney disease, as well as certain ...